Prostatic artery embolization (PAE) offers a safe and minimally invasive solution for addressing lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) [7]. Traditionally, PAE has been conducted through TFA. However, TRA provides multiple benefits, including enhanced safety profiles due to decreased complications at the access site. It contributes to patient satisfaction by enabling leg elevation during lengthy procedures, relieving lower back pain, and facilitating early post-procedure ambulation, which can assist in urination. Additionally, it offers potential cost savings for the department, including reduced reliance on closure devices used for transfemoral access, as well as shorter hospital stays and decreased postprocedural nursing care [1–6]
Visceral artery access may be advantageous via RA compared with FA as the angle of the mesenteric vessels ostia may be more favourable from the cranial approach. This may also be true of pelvic intervention in an ageing population with increased iliac vessel tortuosity.
Many vasculopathic patients requiring intervention have co-morbid conditions prohibiting groin access. Obesity, previous CFA endarterectomy healed surgical incisions, hernia repairs, and concurrent femoral vein cannulation can all contribute to “complicated groins” necessitating the use of alternative access such as RA.
RA confers a high technical success rate even in palpation guided puncture with low conversion rates to FA. Cardiologists rely upon the Barbeau test [8–13]- a modified Allen’s test to manually assess vessel patency. The Barbeau test evaluates the ulnar artery's ability to compensate for temporary occlusion of the targeted radial artery before performing TRA, with the aim of preventing ischemic hand complications. A pulse oximeter is placed on the patient's corresponding thumb to continuously monitor and record the waveform. The radial artery is compressed for two minutes, then released, and the pulse waveform is observed. Waveforms categorized as A-C suggest the patency of the ulnopalmar arch, indicating the safe feasibility of TRA. Conversely, waveform type D suggests inadequate arterial collateralization, thereby contraindicating TRA in such cases [6]. IR can improve success rate even further with the addition of ultrasound [14, 15]. Given our expertise in imaging, the need for performing the Barbeau test is obviated. Ultrasound quickly and effectively pre-empt radial associated issues:
-
pre-determine if there is variant or aberrant anatomy of the radial artery [16]
-
assess spectral Doppler to evaluate proximal stenoses/occlusion;
-
assess the ulnar artery;
-
measure the lumen size in order to approximate sheath Fr; and of course for guided puncture of the radial artery.
The Society of Interventional Radiology quality improvement standards on radial artery access [17] cite Barbeau waveform D as an absolute contraindication to RA. Our method obviates the need for Barbeau evaluation. In this study, the anatomical variant rate was 7%, which is similar to the rate reported in the published literature [15]. Specifically, three patients exhibited a high origin of the radial artery from the brachial artery in the arm, while one patient presented with a radial loop that could not be traversed.
The technique proposed in this study involves administering 500 micrograms of sublingual glyceryl trinitrate (GTN) five minutes prior to puncture. The advantages demonstrated in this study include an increase in radial artery diameter, thus facilitating the radial artery puncture process, and a reduction in post-puncture radial artery spasm. Although occasional instances of radial artery spasm were encountered despite the administration of sublingual GTN, these occurrences were typically mild and did not hinder the manipulation of the wire and catheter through the radial artery. If necessary, an additional 100 micrograms of intra-arterial GTN were administered through the sheath. It is noteworthy that in all 62 procedures included in this study, this approach was successfully implemented. We find this approach practical, easy, and time-efficient, enabling rapid puncture of the radial artery. We also administer the same dose of GTN sublingually to our PAE patients undergoing planning pelvic CT angiography so they are already familiar with its side effects prior to the procedure itself.
An alternative method, well-described in cardiology literature and frequently employed by interventional radiologists during radial punctures, entails applying a proprietary topical GTN cream (2%) or a blend of 2% GTN and anaesthetic cream (EMLA - Eutectic Mixture of Local Anaesthetics Cream) to the wrist an hour before the procedure [2, 5, 6]. However, we find this technique unnecessary and time-consuming. We advocate for the use of sublingual GTN as a more efficient option, enabling the commencement of the procedure in a shorter time.
Similarly, cardiology and radiology literature describe the use of local anaesthesia consisting of a mixture of 1 mL of 100 µg of GTN and 9 mL of 1% lidocaine delivered to the subcutaneous tissues around the left radial artery under ultrasound guidance [2, 5, 11]. In our experience, 2–3 ml of 1% lignocaine is sufficient for local anesthesia.
Various 'cocktails' have been proposed to prevent radial artery spasm post-puncture [2, 5, 6, 12]. The most commonly used cocktail includes 2000 IU of heparin, 200 mg of GTN, and 2.5 mg of verapamil. However, this “cocktail” causes discomfort in the hand when injected. To reduce this discomfort, these medications are drawn up into a 20 mL syringe, and following access, blood is aspirated into the syringe to the full 20 mL volume via the sheath, then reinjected over 30 seconds. Despite the dilution and slow injection, many patients still experience discomfort in the hand, and verapamil's negative inotropic effect can induce hypotension, particularly at doses > 2.5 mg. We utilize smaller sheaths, 4F and 5F, compared to the standard 6F and 7F sheaths used by cardiologists, increasing the likelihood that cardiologists will encounter radial artery spasm, necessitating higher doses and frequencies of antispasmodic medications. In our experience, administering sublingual GTN just before starting the procedure significantly reduces radial artery spasm. Once the sheath is inserted, it is connected it to a continuous infusion pump of heparinized normal 0.9% saline at a rate of 60 ml per hour. Then, as the catheter and wire are manipulated to the aortic arch, 3000 IU of heparin is administered in the arch, followed by 1000 units of heparin every hour after two hours of procedure time. As the heparin is injected in the aortic arch and not in a small artery like the radial artery it will not cause any discomfort to the patient.
Recent IR studies have investigated the effectiveness of TRA and concluded that there are no significant differences in adverse events, radiation exposure, procedure duration, or clinical success rates compared to TFA [3, 4]. In a recent retrospective analysis, the procedural outcomes and adverse events of 998 patients undergoing PAE at a single center between April 2014 and August 2022 were examined [5]. Of these, 821 patients (82%) underwent TRA PAE, while 177 patients (18%) underwent TFA PAE. TRA PAE demonstrated comparable technical success to TFA PAE, with lower incidence of access site hemorrhagic complications and reduced radiation requirements. However, the interpretation of the findings regarding the favorable procedural time and radiation profile for TRA versus TFA is complicated by the learning curve and subsequent preference for TRA by the single interventional radiologist.
Another advantage of TR is operator ionizing radiation dose is most likely reduced when using TRA vs TFA given the increased distance from the primary beam [18]. As mentioned above. patient radiation dose and procedure time are largely unaffected by access in PAE [3, 4] and in cardiology cases [18–21].
While cardiologists typically favour the right radial artery for radial access (RA), we advocate for the use of the left radial artery. This approach eliminates the need to traverse the aortic arch during typical infradiaphragmatic interventions, thereby minimizing contact with major vessels and theoretically reducing the risk of stroke. It is important to acknowledge the rare complication of stroke; however, it is crucial to put this rare risk into perspective. Reported data often refers to asymptomatic strokes and includes cardiology procedures that involve crossing the arch in each case. The reported stroke rate in the published radiology literature about TRA PAE is 0.2 to 0.7% [5, 6].
Both pneumatic (for TRA) and elastic (for DRA) patent haemostasis devices are readily available and inexpensive [22]. “Do-it-yourself” alternatives and manual compression are also viable [23]. All options have a relatively short learning curve compared with closure devices typically used for antegrade or retrograde FA. Short duration and lowest required pressure for patent haemostasis is recommended to reduce the risk of RAO.
RAO is the biggest access related complication from RA, occurring 2–3% of the time [8, 24]. Pathophysiology of acute RAO results from one of, or a combination of: thrombosis, dissection, local hypercoaguable states, and/or compressive haemostasis (low flow). Due to significant collateral supply (especially in the case of DRA using the superficial arch) RAO is usually asymptomatic [25]. Whereas the CFA is in effect an end vessel - equivalent complications related to access can be catastrophic, particularly in vasculopathic patients we often encounter in IR. However, RAO does preclude future re-intervention from RA. For IR procedures reintervention rate is variable but FA can always be resorted to. RAO also precludes the radial artery being utilised as a conduit in CABG, since radial conduits have been shown to be preferential to traditional saphenous vein grafts. This again may be co-morbid requirement in our IR patient population given the vasculopathic nature. Furthermore, RAO precludes radial artery use in formation of an AVF for haemodialysis access. This may be particularly pertinent when considering left RA in high population prevalence of right hand dominance and a subsequent preference for left arm fistulae. Again, renal failure is likely to be co-morbid in our patient group. In order to reduce the risk of RAO, several factors can be optimised.
Peri-procedural heparin, either systemic or intra-arterial at a recommended dose of 5000 units and aspirin have been demonstrated to reduce RAO. We do not routinely commence aspirin pre-procedure for our PAE patients, but we do not discontinue it if it has been prescribed for another reason. We describe our heparin regime, 3000 IU of heparin administered in the aortic arch, followed by 1000 units of heparin every hour after two hours of procedure time, in combination with continuous infusion of heparinised saline throughout the procedure to reduce the risk of thrombosis around the sheath and subsequent RAO. This will also reduce the initial heparin bolus required and reduce bleeding risk [26]. Sheath size is an important consideration for RA, as sheath:artery ratio > 1 is associated with increased RAO risk. Infact, The Society of Interventional Radiology quality improvement standards on radial artery access cite “Radial artery anterior-posterior inner-to-inner wall diameter on ultrasound not compatible with the outer diameter of the introducer sheath” as an absolute contraindication to RA. We exclude any patient with radial artery diameter less than 2 mm. Multiple puncture attempts are associated with increased RAO rates and ultrasound guidance should reduce puncture attempts and as such reduce RAO risk further.
In PCI, RA is associated with reduced bleeding risk compared with FA. This may be in part due to the forearm offering only a small potential space around the puncture site wherein haematoma can collect unnoticed [27]. In cases of PCI, the patients are often receiving therapeutic anticoagulation and antiplatelet medication. In our elective PAE procedures, these can be temporarily withheld, in line with European best practice (CIRSE anticoagulation and antiplatelet protocols). As such, this should further reduce the bleeding risk associated with vascular access via RA. However, compartment syndrome is still a potential complication of RA [28], radial artery pseudoaneurysm [29, 30] and radial artery avulsion [31] have all been reported in RA.
RA is associated with early patient mobilisation, even over FA with successful deployment of closure devices. As a result, patients will need less nursing care. A survey published in 2020 revealed nurses tend to prefer radial over femoral access when caring for patients who have undergone interventional radiology procedures, independent of years of experience [32]. However, there is no significant difference in the length of stay between TRA and TFA.
A cross-national survey was undertaken among interventional radiologists in Europe and the United States to evaluate the utilization of RA within this community, along with its perceived benefits and drawbacks [33]. The survey demonstrated that the main barriers for TRA adoption by IRs are the perception that it is associated with longer learning curve, potential increased risk of stroke, longer procedural time and increase in radiation exposure. However, current literature indicates that these are only misperceptions and perceived limitations or obstacles [1–6, 33].
To encourage interventional radiologists to advocate for radial access, we suggest incorporating it into the IR training curriculum. IR trainees should spend part of their training in centers where radial access is frequently used. If this opportunity is not available, their training programs should collaborate with cardiology services to allow IR trainees to spend some time in the cath lab learning radial access.
We are unable to extrapolate any of our data to female patients due to the nature of the procedure studied herein. This is a limitation of this study given that RAO risk is greater in smaller vessels and is associated with female sex. Equally we have no expertise nor experience in paediatric populations.